Home | Welcome to Contract Pharma   
Last Updated Wednesday, April 1 2015

Print RSS Feed

Search Results for 'MDS Pharma Services'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

By Kristin Brooks
Published April 8, 2010
Ricerca CEO Ian Lennox discusses the acquisition of MDS Pharma Services Read More »
Published June 1, 2009
MDS, Inc. is divesting its Phase II-IV operations to INC Research for $50 million. MDS plans to focus on early stage discovery through Phase IIa CRO services. Read More »
Published January 7, 2009
Rudy Howard has been named senior vice president and chief financial officer, MDSPS. Mr. Howard has experience as a senior financial executive in the pharmaceutical and CRO industry sectors, including six years as chief financial officer at Pharmaceu… Read More »
Published June 23, 2008
Dr. Patrice Hugo has been named vice president of scientific affairs for the global central lab network of MDS Pharma Services. In this role, he will lead the development of innovative biomarkers and esoteric assays to enhance clinical development pr… Read More »
Published October 30, 2007
MDS Pharma Services has moved its central lab services to a new, larger facility in Beijing to meet growing demands from pharmaceutical and biotech companies conducting clinical trials in China. With almost 25,000 sq. ft., the new facility offers… Read More »
Published May 11, 2007
Dr. James M. Pusey has been appointed vice president and general manager of MDS Pharma Services global clinical development business, which manages late-stage drug trials. Dr. Pusey has more than 25 years of experience in medicine, global clinical tr… Read More »
Published June 15, 2006
MDS Pharma Services has been ranked the top contract research organization (CRO) in Europe in a survey of clinical trial investigators by Thomson CenterWatch. "This recognition adds to MDS Pharma Services' reputation as a world-class, marke… Read More »
Published January 23, 2006
MDS Pharma Services has been selected as the preferred contract research organization (CRO) of the Multiple Myeloma Research Consortium (MMRC). MDS will manage multiple MMRC preclinical and clinical research efforts, including data management related… Read More »
By Gil Y. Roth
Published August 22, 2005
Editor Gil Y. Roth continues our profiles of the top companies in pharma and biopharma outsourcing. Read More »
Published November 18, 2011
Will work to further develop company‚Äôs clinical data solution Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On